Clinical trials
OVARIAN STIMULATION clinical trials
Below are recruiting ovarian stimulation clinical trials, each written for real people, not researchers. We’re tracking 27 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06572930Recruiting
Monitoring FSH for better ovarian stimulation
This study looks at whether tracking a hormone called FSH during ovarian stimulation can help find the best level for egg development. It may help improve your chances in fertility treatment.
Abu Dhabi, Abu Dhabi EmirateAges 18–39 - NCT07409493Recruiting
Comparing two IVF methods with time-lapse imaging
This study compares two types of ovarian stimulation protocols (PPOS and GnRH antagonist) for women undergoing IVF with a freeze-all embryo plan. It uses time-lapse imaging to see if one approach leads to better embryo development.
HanoiAges 20–45 - NCT06212102RecruitingPhase 2
Comparing two drugs for poor responders in double ovarian stimulation
This trial compares dydrogesterone with a GnRH antagonist to see which works better for women with a low number of eggs (poor responders) who are undergoing two rounds of egg retrieval in one cycle. It may help improve outcomes for those with specific fertility challenges.
Cairo, Cairo GovernorateAges 35–44 - NCT06064669Recruiting
Metformin for healthy live birth in women with prediabetes
This study tests if metformin, a drug that helps control blood sugar, can improve the chance of a healthy live birth in women with prediabetes who are doing in vitro fertilization (IVF). It aims to see if treating prediabetes before and during early pregnancy leads to better outcomes.
Jinan, ShandongAges 20–40 - NCT06175832RecruitingPhase 4
Two Hormone Protocols for Egg Growth in First IVF or Egg Freezing
This trial compares two hormone protocols for ovarian stimulation in women having their first cycle—either to freeze eggs for fertility preservation or for IVF with genetic testing. The goal is to see which method leads to more usable eggs while being easier on the patient.
GhentAges 18–40 - NCT06910293Recruiting
Brain Activity During Menstrual Cycle vs. Fertility Treatment
This study looks at how natural menstrual cycles and ovarian stimulation (which mimics some fertility treatments) affect brain activity and hormone levels. Researchers want to understand normal brain changes during the cycle to help improve fertility treatments.
Abu Dhabi, Abu Dhabi EmirateAges 25–35 - NCT06739759Recruiting
Preventing OHSS in PCOS women having ICSI
This trial tests a way to prevent a side effect called ovarian hyperstimulation syndrome (OHSS) in women with PCOS who are having ICSI (a type of IVF). The goal is to make fertility treatment safer for you.
GizaAges 19–42 - NCT05316129RecruitingPhase 1
Trial of your own engineered T cells for ovarian cancer
This Phase 1 study tests whether giving your own immune cells—engineered to target the FSH receptor—can control recurrent ovarian-related cancers. It’s mainly looking at safety and early signs of activity for patients whose cancer has not responded well to standard platinum chemotherapy.
Tampa, FloridaAges 18 years+ - NCT04390308Recruiting
Testing gentle stimulation of ovaries before fertility treatment
This trial studies whether a “mechanical stimulation” procedure can help small egg-making structures in the ovary start to work again in people with primary ovarian insufficiency. If the procedure shows signs of response, you may then move on to further fertility treatment, including IVF.
Abu Dhabi, Abu Dhabi EmirateAges 18–40 - NCT06244745RecruitingPhase 3
Letrozole after ovarian stimulation in egg donors
This study tests whether giving the drug letrozole after ovarian stimulation can help egg donors. The goal is to see if it reduces the risk of ovarian hyperstimulation syndrome, a side effect that can happen after donating eggs.
MadridAges 18–34 - NCT06023602Recruiting
Generic vs. brand-name cetrorelix for IVF ovarian stimulation
This trial compares a generic version of cetrorelix acetate (a medication used to control ovulation) to the brand-name version during IVF. It aims to see if the generic works just as well for women undergoing ovarian stimulation.
Xi'an, None SelectedAges 20–42 - NCT04719000RecruitingPhase 4
Personalized LH addition during IVF to improve egg growth
This trial tests whether adding a personalized amount of “LH” during IVF hormone stimulation can help your ovaries respond better. It may be useful if you’ve had a weaker IVF response before and fit specific age and egg-quality markers.
BarcelonaAges 35–40 - NCT07515118Recruiting
Using AI to improve egg-stimulation timing for IVF
This study tests artificial intelligence to optimize when doctors trigger egg release during IVF treatment. Better timing may improve egg quality and IVF success rates. You'll have all ultrasound monitoring at the study center.
Sabadell, BarcelonaAges 18–42 - NCT06732843Recruiting
Comparing two IVF medications for egg and embryo quality
This study compares two fertility medications (rFSH and hMG) to see how they affect the cells around your eggs and the quality of embryos. It may help you and your doctor choose the best stimulation drug for your IVF cycle.
Abu Dhabi, Abu Dhabi EmirateAges 18–38 - NCT07110285Recruiting
AI vs. doctor decision for IVF trigger day
This trial compares an artificial intelligence (AI) algorithm to doctors to decide the best day to give the trigger shot during IVF. It aims to see if AI can improve the number of mature eggs retrieved.
HerzliyaAges 18–45 - NCT07153367RecruitingPhase 2
Study of a fixed dose of Rekovelle for IUI treatment
This trial tests a fixed dose of the hormone follitropin delta (Rekovelle) to stimulate the ovaries before intrauterine insemination (IUI). It aims to see if this approach works well for women with regular cycles who are starting IUI for the first time.
BrugesAges 18–38 - NCT04163133Recruiting
Timing changes during ovarian stimulation for IVF
This study tests whether changing the timing of hormones during ovarian stimulation can improve IVF results for people with certain ovarian reserve levels. It may help find a stimulation approach that works better for first-time (or second) IVF cycles.
Beijing, Beijing MunicipalityAges 18–42 - NCT06545877Recruiting
Survey of REKOVELLE for fertility treatment
This survey collects information from people who have already used REKOVELLE (a medication that helps the ovaries produce eggs) as part of their fertility treatment. Taking part will help researchers learn how the medication works in real-world daily practice.
Omitama, IbarakiAges Any age - NCT06280560Recruiting
IVF hormones and womb lining health study
This study looks at how IVF hormone treatments affect the womb lining and whether they cause aging cells to build up. It may help doctors improve IVF success rates.
ValenciaAges 18–45 - NCT06839274Recruiting
Follicle size and egg maturity in poor responders
This trial looks at how the size of ovarian follicles (fluid sacs that contain eggs) affects egg maturity in women who have a low egg count. It may help improve egg freezing or IVF success.
Abu Dhabi, Abu Dhabi EmirateAges 18–48 - NCT07462065RecruitingPhase 4
Clomiphene with or without Pioglitazone for PCOS
This study compares two fertility treatments: clomiphene alone or clomiphene plus pioglitazone. It aims to see if adding pioglitazone improves ovarian stimulation in women with PCOS.
Islamabad, FederalAges 18–38 - NCT06701071RecruitingPhase 4
Comparing short vs long Clomid for IVF stimulation
This study tests whether a shorter or longer course of Clomid (a fertility medicine) works better for women who are expected to have a low response to ovarian stimulation. It may help those with a lower egg reserve still produce enough eggs for IVF.
Pasadena, CaliforniaAges 18–44 - NCT06635538Recruiting
One-shot ovarian stimulation protocol for fertility
This trial tests a 'one-shot' ovarian stimulation protocol (a single injection to help your ovaries produce eggs). It is for women with good ovarian reserve who fit certain age and health requirements, and aims to simplify the treatment process.
Sabadell, BarcelonaAges 18–40 - NCT06921395RecruitingPhase 4
Comparing two fertility drugs for IVF in women under 40
This trial tests how well and safely a new drug (Fang Le Shu) works compared to a standard drug (Guo Na Fen) for stimulating the ovaries to produce eggs for IVF. It may help women who have had trouble getting pregnant for at least a year.
ZhengzhouAges 20–39
Hear when a new OVARIAN STIMULATION trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ovarian stimulation?
- Yes. Clin2 currently lists 27 recruiting ovarian stimulation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ovarian stimulation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ovarian stimulation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.